Cell Design Labs Overview

  • Founded
  • 2015

Founded
  • Status
  • Acquired/​Merged

  • Employees
  • 8

Employees
  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $472M

  • Investors
  • 1

Cell Design Labs General Information

Description

Developer of cell-based disruptive therapies designed to offer treatment for cancer and other devastating diseases. The company's therapies include disruptive T cell receptor therapies that modifies the body's immune cells to create therapeutic agents capable of selectively recognizing, disabling and destroying malignant threats, enabling medical researchers to develop cell-based therapies efficiently.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Acquirer
Primary Office
  • 5858 Horton Street
  • Suite 240
  • Emeryville, CA 94608
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cell Design Labs Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 01-Dec-2017 $472M 000.00 00000 Completed Generating Revenue
3. Later Stage VC (Series C) 16-Jun-2016 000 000.00 0000 Completed Generating Revenue
2. Early Stage VC (Series B) 21-Dec-2015 $22.9M $30.7M 000.00 Completed Generating Revenue
1. Early Stage VC (Series A) $7.8M $7.8M 000.00 Completed Generating Revenue
To view Cell Design Labs’s complete valuation and funding history, request access »

Cell Design Labs Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C 0,000,000 00.000000 00 00.0 00.0 00 00.0 0.000
Series B 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A 3,900,940 $0.000100 6% $2 $2 1x $2 24.12%
To view Cell Design Labs’s complete cap table history, request access »

Cell Design Labs Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of cell-based disruptive therapies designed to offer treatment for cancer and other devastating diseases. The
Biotechnology
Emeryville, CA
8 As of 2016
000.00
0000 0000-00-00
000000&0 000.00

000000

t, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. U
0000 000000000
Philadelphia, PA
00 As of 0000
00000
0000 0000-00-00
00000000000 00000

0000 0

ris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate vel
0000 000000000
South San Francisco, CA
000 As of 0000
00000
0000 0000-00-00
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Cell Design Labs Competitors (75)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Carisma Therapeutics Venture Capital-Backed Philadelphia, PA 00 00000 00000000000 00000
0000 000000 Venture Capital-Backed South San Francisco, CA 000 00000 00000000000 00000
000000000 00000000 Venture Capital-Backed Newark, CA 0 000.00 0000000000 0 000.00
000000000000000 Venture Capital-Backed Saint Louis, MO 00 000.00 00000000000 000.00
000000 Venture Capital-Backed Utrecht, Netherlands 00 00.000 0000000000 0 00.000
You’re viewing 5 of 75 competitors. Get the full list »

Cell Design Labs Patents

Cell Design Labs Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3755712-A1 Chimeric transmembrane receptors and uses thereof Pending 21-Feb-2018 000000000
US-20200384030-A1 Chimeric transmembrane receptors and uses thereof Pending 21-Feb-2018 000000000
US-20190194617-A1 Single- and multi-chain chimeric antigen receptors Pending 22-Dec-2017 0000000000
EP-3728322-A1 Single- and multi-chain chimeric antigen receptors Pending 22-Dec-2017 0000000000
US-20190194340-A1 Methods of making bispecific anti-cd307e and anti-bcma chimeric antigen receptors and uses of the same Pending 29-Sep-2017 C07K16/2878
To view Cell Design Labs’s complete patent history, request access »

Cell Design Labs Executive Team (6)

Name Title Board Seat Contact Info
Wendell Lim Ph.D Scientific Founder
Gregory Giotta Ph.D Senior Vice President Intellectual Property
Fred Cohen Ph.D Chairman & Co-Founder
You’re viewing 3 of 6 executive team members. Get the full list »

Cell Design Labs Board Members (6)

Name Representing Role Since
Fred Cohen Ph.D Self Chairman & Co-Founder 000 0000
You’re viewing 1 of 6 board members. Get the full list »

Cell Design Labs Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cell Design Labs Former Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Arie Belldegrun Angel (individual) Minority 000 0000 000000 0
Bellco Capital Family Office Minority 000 0000 000000 0
Brian Atwood Angel (individual) Minority 000 0000 000000 0
Kleiner Perkins Venture Capital Minority 000 0000 000000 0
Mission Bay Capital Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »